Recombinant human TARC/CCL17 protein (ab9817)
Key features and details
- Expression system: Escherichia coli
- Purity: > 99% SDS-PAGE
- Active: Yes
- Suitable for: SDS-PAGE, Functional Studies
製品の詳細
-
製品名
Recombinant human TARC/CCL17 protein
TARC/CCL17 タンパク質・ペプチド 製品一覧 -
精製度
> 99 % SDS-PAGE.
Sterile filtered Greater than 99% pure by HPLC analyses. Endotoxin level is less than 0.1 ng per g (1EU/g). -
発現系
Escherichia coli -
タンパク質長
Full length protein -
Animal free
No -
由来
Recombinant -
-
生物種
Human -
予測される分子量
11 kDa
-
特性
Our Abpromise guarantee covers the use of ab9817 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
アプリケーション
SDS-PAGE
Functional Studies
-
製品の状態
Lyophilized -
備考
The biological activity of this product is determined by its ability to chemoattract human T-lymphocytes using a concentration range of 1.0-10.0 ng/ml.This product was previously labelled as TARC
-
Concentration information loading...
前処理および保存
-
保存方法および安定性
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
-
再構成Please reconstitute this product in 200ul water.
関連情報
-
別名
- A-152E5.3
- A152E53
- ABCD 2
see all -
機能
Chemotactic factor for T-lymphocytes but not monocytes or granulocytes. May play a role in T-cell development in thymus and in trafficking and activation of mature T-cells. Binds to CCR4. -
組織特異性
Expressed at high levels in thymus and at low levels in the lung, colon and small intestine. -
配列類似性
Belongs to the intercrine beta (chemokine CC) family. -
細胞内局在
Secreted. - Information by UniProt
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
参考文献 (1)
ab9817 は 1 報の論文で使用されています。
- Goldie SJ et al. Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis. Cell Death Dis 9:1072 (2018). PubMed: 30341279